Abstract
Chronic infection with hepatitis C virus (HCV) may be complicated by the development of systemic vasculitis. Vasculitis is either caused by mixed cryoglobulinemia or a non-cryoglobulinemic vasculitis resembling polyarteritis nodosa (PAN). Antiviral treatment with interferon-α (IFN) and subsequent clearing of HCV mostly leads to improvement of vasculitic symptoms, but vasculitis may also be exacerbated and even cases of new onset of vasculitis may occur. Exacerbations of both cryoglobulinemic and PAN-type vasculitis in chronic HCV infection have been described under treatment with IFN. The most common symptom is vasculitic neuropathy. However, peripheral neuropathy in a HCV-infected patient treated with IFN may also be caused by direct neurotoxic or antiangiogenic effects of IFN itself, often requiring a nerve biopsy to establish the exact diagnosis. The clinical course of vasculitic complications of IFN treatment is variable and ranges from regression of symptoms despite continuation of IFN treatment to fatal exacerbations despite termination of IFN treatment and additional immunosuppressive therapy. In most cases of IFN-induced vasculitis, immunosuppressive therapy with corticosteroids has been employed, leading to improvement of symptoms. We report the case of a patient with chronic HCV infection who first developed cryoglobulinemic vasculitis after initiation of therapy with the polyethylene glycol (PEG)-conjugated form of IFN (PEG-IFN) and discuss it in the context of the relevant literature. First onset of cryoglobulinemic vasculitis after initiation of IFN therapy has not been described so far.
Similar content being viewed by others
References
Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette J et al (1999) Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 42:2204–2212
Boonyapisit K, Katirji B (2002) Severe exacerbation of hepatitis C associated vasculitic neuropathy following treatment with interferon alpha. A case report and literature review. Muscle Nerve 25:909–913
Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L et al (2001) Systemic vasculitis in patients with hepatitis C. J Rheumatol 28:109–118
Agnello V, Abel G (1997) Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 40:2007–2015
Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M et al (1994) Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300
Donada C, Crucitti A, Danodon V, Tommasi L, Zanette G, Crovatto M et al (1998) Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinemia. J Viral Hep 5:179–185
Agnello V (2000) Mixed cryoglobulinemia and other extrahepatic manifestations of hepatitis C virus infection. In: Liang HJ (ed) Hepatitis C. Academic, San Diego, pp 295–313
Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S et al (1992) Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 19:889–895
Cacoub P, Renou C, Kerr G, Hue S, Rosenthal E, Cohen P et al (2001) Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44:2118–2124
Naarendorp M, Kallemuchikkal U, Nuovo G, Gorevic P (2001) Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol 28:2466–2473
Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P et al (2002) Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46:3317–3326
Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi P et al (1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751–756
Fattovich G, Giustina G, Favarato S, Ruol A (1996) A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 24:38–47
D’Amico G (1998) Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54:650–671
Wilson L, Widman D, Dikman S, Gorevic P (2002) Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 32:163–173
Harle J-R, Disdier P, Pelletier J, Azulay J-P, Perreard M, Weiller J-P (1995) Dramatic worsening of hepatitis C-related cryoglobulinemia subsequent to treatment with interferon alfa. JAMA 275:126
Zimmermann R, Konig V, Bauditz J, Hopf U (1993) Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinemia, and chronic hepatitis C. Lancet 341:561–562
Batisse D, Karmochkine M, Jacquot C, Kazatchkine MD, Weiss L (2004) Sustained exacerbation of cryoglobulinemia-related vasculitis following treatment of hepatitis C with peginterferon alfa. Eur J Gastroenterol Hepatol 16:701–703
Lidove O, Cacoub P, Maisonobe T, Thibault V, Piette J-C, Lèger J-M (2001) Hepatitis C virus with peripheral neuropathy is not always associated with cryoglobulinemia. Ann Rheum Dis 60:290–292
Paoletti V, Donnarumma L, De Matteis A, Mammarella A, Labbadia G, Musca A et al (2000) Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection. Panminerva Med 42:175–178
Gupta R, Singh S, Tang R, Blackwell T, Schiffman J (2002) Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med 112:683–684
Cid M, Hernandez-Rodriguez J, Robert J, Del Rio A, Casademont J, Coll-Vinent B et al (1999) Interferon-α may exacerbate cryoglobulinemia-related ischemic manifestations. Arthritis Rheum 42:1051–1055
Lidove O, Cacoub P, Hausfater P, Wechsler B, Frances C, Leger J-M et al (1999) Hepatitis C virus and cryoglobulinemia: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 23:403–406
Negoro K, Fukusako T, Morimatsu M (1994) Acute axonal polyneuropathy during interferon a-2a therapy for chronic hepatitis type C. Muscle Nerve 17:1351–1352
Zuber M, Gause A (1997) Peripheral neuropathy during interferon-a therapy in patients with cryoglobulinemia and hepatitis virus infection. J Rheumatol 24:2488–2489
Jefferson J, Johnson R (2000) Treatment of hepatitis C-associated glomerular disease. Semin Nephrol 20:286–292
Gorevic P, Kassab H, Levo Y, Kohn R, Meltzner M, Prose P et al (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287–308
Gupta G, Holmes S, Spence E, Mills P (2000) Capillaritis associated with interferon-alfa treatment of chronic hepatitis C infection. J Am Acad Dermatol 43:937–938
Friedmann G, Mehta S, Sherker A (1999) Fatal exacerbation of hepatitis C related cryoglobulinemia with interferon-α therapy. Dig Dis Sci 44:1364–1365
Kokado Y, Takahara S, Ichimaru N, Toki K, Wang J, Permpongkosol S et al (2000) Clinical outcome of HCV infection after renal transplantation. Transplant Proc 32:1940–1943
Paterton D, Fain O, Sehonnou J, Trinchet J, Beugrand M (1996) Severe necrotizing vasculitis in a patient with hepatitis C virus infection treated by interferon. Clin Exp Rheumatol 14:79–81
La Civita L, Pasero G, Ferri C (1997) Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol 24:1656–1657
Ferri C, La Civita L, Fazzi P, Pasero G (1996) Polymyositis, lung fibrosis and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 39:1074–1075
Gordon A, Edgar JD, Finch R (1998) Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J Infect 36:229–230
Scelsa S, Herskovitz S, Reichler B (1998) Treatment of mononeuropathy multiplex in hepatitis C virus and cryoglobulinemia. Muscle Nerve 21:1526–1529
Bojic I, Lilc D, Radojic C, Mijuskovic P (1994) Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a. J Gastroenterol 29:369–371
Tambini R, Quattrini A, Fracasetti O, Nemni R (1997) Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C. J Rheumatol 24:1656–1657
Quatrini A, Comi G, Nemni R, Martinelli V, Villa A, Caimi M et al (1997) Axonal neuropathy associated with interferon-a treatment for hepatitis C: HLA-DR immunoreactivity in Schwann cells. Acta Neuropathol 94:504–508
Irioka T, Yamada M, Yamawaki M, Mizusawa H (2001) Acute autonomic and sensory neuropathy after interferon a-2b therapy for chronic hepatitis C. J Neurol Neurosurg Psychiatr 70:408–410
Marzo ME, Tintore M, Fabregues O, Montalban O, Codina A (1998) Chronic inflammatory demyelinating neuropathy during treatment with interferon-α. J Neurol Neurosurg Psychiatr 65:604
Merrigiolli M, Rowin J (2000) Chronic inflammatory demyelinating neuropathy after treatment with interferon-α. Muscle Nerve 23:433–435
Rutkove S (1997) An unusual axonal polyneuropathy induced by low-dose interferon alfa-2a. Arch Neurol 54:907–908
Manesis E, Petrou C, Brouzas D, Hadziyannis S (1994) Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 21:474–477
Fukumoto Y, Shigemitsu T, Omura R, Harada T, Okita K (1994) Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C. Intern Med 33:637–640
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beuthien, W., Mellinghoff, HU. & Kempis, J.v. Vasculitic complications of interferon-α treatment for chronic hepatitis C virus infection: case report and review of the literature. Clin Rheumatol 24, 507–515 (2005). https://doi.org/10.1007/s10067-005-1093-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-1093-x